Biology subjects

Kadlecova, Z.

Publications and source records attributed to Kadlecova, Z..

5 recordsLinked to original sources

bioRxiv2026

Endocytic accessory proteins assemble clathrin while simultaneously destabilizing protein condensates

During endocytosis a dynamic protein network is responsible for assembly of the clathrin coat. Early in the process the Eps15 protein is thought to undergo liquid-liquid phase-separation to form biomolecular condensates. These condensates facilitate clathrin assembly, producing clathrin-coated vesicles that are ultimately excluded from the condensate as the vesicles depart from the plasma membrane. An array of distinct clathrin accessory proteins drive this process, yet their interactions with protein condensates have not been explored. Here we show that clathrin accessory proteins promote the assembly of the clathrin lattice by simultaneously destabilizing protein condensates. By adding diverse accessory proteins to Eps15 condensates, we observed that accessory proteins which cross-linked Eps15 proteins stabilized condensates, while accessory proteins that compete with Eps15-Eps15 interactions destabilized condensates. Interestingly, accessory proteins that destabilized condensates also promoted the assembly of clathrin and its exclusion from condensates. In contrast, accessory proteins that stabilized condensates opposed exclusion of clathrin. Finally, we demonstrated that decreasing condensate stability enhanced clathrin assembly and exclusion, even when no additional clathrin assembly motifs were introduced. Taken together, these results help to explain how condensates can catalyze the assembly of coated vesicles by providing both a substrate for their initiation and a driving force for their exclusion and ultimate departure. Statement of SignificanceThis work is significant because it reveals how biomolecular condensates could actively drive, rather than merely host, clathrin-mediated endocytosis. By showing that clathrin accessory proteins can tune condensate stability to simultaneously promote clathrin lattice assembly and exclusion, this study uncovers a physical mechanism that could link phase separation to membrane trafficking. The finding that condensate destabilization alone enhances clathrin exclusion reframes condensates as dynamic regulators that could provide both an initiation platform and a force for vesicle maturation and release. More broadly, this work advances our understanding of how cells coordinate assembly and disassembly of complex macromolecular structures through regulated changes in condensate material properties.

biophysics↗

bioRxiv2026

Shape2Fate: a morphology-aware deep learning framework for tracking endocytic and exocytic carriers at nanoscale.

Plasma membrane homeostasis requires balanced exocytosis and endocytosis, yet their coordination at the single-event level in non-neuronal cells is unresolved. We present Shape2Fate, a morphology-aware deep-learning pipeline that detects, tracks, and classifies individual exocytic and endocytic carriers in live-cell total internal reflection fluorescence structured illumination microscopy (TIRF-SIM) movies at [~]100 nm resolution. Trained on synthetic data and exploiting carrier shape evolution rather than fluorescence intensity, Shape2Fate achieves expert-level tracking and outcome classification across diverse cell types, imaging conditions, and microscope platforms. Applying Shape2Fate to constitutive secretion and insulin-stimulated GLUT4 exocytosis in adipocytes, we uncover two opposing exo-endocytic coupling architectures: exocytic fusion locally nucleates de novo clathrin-coated pits, whereas GLUT4 vesicles target pre-existing pits for rapid cargo capture. These findings establish that the spatial rules governing exo-endocytic coordination are not universal but are pathway-specific. Shape2Fate is openly available, enabling direct event-level mechanistic dissection of exo-endocytic coordination across pathways in living cells.

cell biology↗

bioRxiv2025

Development of pyrazolopyrimidine based macrocyclic kinase inhibitors targeting AAK1

Since the outbreak of SARS-CoV-2 in recent years, our society has become more aware that zoonotic diseases pose a real threat. Therefore, the demand for small molecules that target host proteins, essential for viral entry and replication, has increased as an interesting strategy for the development of antiviral agents, as these agents may be effective against several different pathogens. NAK kinases is one such potential target family because they are involved in a variety of cellular functions, hijacked by viruses to invade host cells, such as clathrin-mediated endocytosis. A large number of different inhibitors have already been reported targeting NAK kinases, but there are still no compounds that selectively target AAK1 over other NAK family members, in particular the closely related family member BIKE. Here, we developed a series of pyrazolo[1,5-a]pyrimidine-based macrocyclic NAK inhibitors, starting from the acyclic AAK1 inhibitor LP-935509. Through a structure-guided activity relationship study within the NAK family, we identified potent AAK1 inhibitors 16, 18 and 27, which show promising selectivity within the NAK family. The inhibitors showed a potent inhibition of the phosphorylation of the AP-2 complex and the antiviral activity of the compounds was evaluated against various RNA viruses.

biochemistry↗

bioRxiv2024

Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons

Mutation of the ATL1 gene is one of the most common causes of hereditary spastic paraplegia (HSP), a group of genetic neurodegenerative conditions characterised by distal axonal degeneration of the corticospinal tract axons. Atlastin-1, the protein encoded by ATL1, is one of three mammalian atlastins, which are homologous dynamin-like GTPases that control endoplasmic reticulum (ER) morphology by fusing tubules to form the three-way junctions that characterise ER networks. However, it is not clear whether atlastin-1 is required for correct ER morphology in human neurons and if so what the functional consequences of lack of atlastin-1 are. Using CRISPR-inhibition we generated human cortical neurons lacking atlastin-1. We demonstrate that ER morphology was altered in these neurons, with a reduced number of three-way junctions. Neurons lacking atlastin-1 had longer endosomal tubules, suggestive of defective tubule fission. This was accompanied by reduced lysosomal proteolytic capacity. As well as demonstrating that atlastin-1 is required for correct ER morphology in human neurons, our results indicate that lack of a classical ER-shaping protein such as atlastin-1 may cause altered endosomal tubulation and lysosomal proteolytic dysfunction. Furthermore, they strengthen the idea that defective lysosome function contributes to the pathogenesis of a broad group of HSPs, including those where the primary localisation of the protein involved is not at the endolysosomal system.

cell biology↗

bioRxiv2022

FCHO controls AP2's critical endocytic roles through a PtdIns4,5P2 membrane-dependent switch

Clathrin-mediated endocytosis (CME) is the main mechanism by which mammalian cells control their cell surface proteome. Proper operation of the pivotal CME cargo-adaptor AP2 requires membrane-localised FCHO. Here, live-cell eTIRF-SIM shows that FCHO marks sites of clathrin- coated pit (CCP) initiation, which mature into uniform sized CCPs comprising a central patch of AP2 and clathrin corralled by an FCHO/Eps15 ring. We dissect the network of interactions between the FCHO interdomain-linker and AP2, which concentrates, orients, tethers and partially destabilizes closed AP2 at the plasma membrane. AP2s subsequent membrane deposition drives its opening, which triggers FCHO displacement through steric competition with PtdIns4,5P2, clathrin, cargo and CME accessory factors. FCHO can now relocate toward a CCPs outer edge to engage and activate further AP2s to drive CCP growth/maturation. 125 character summaryFCHO primes AP2 for CCV incorporation, a process that triggers FCHO release to enable activation/recruitment of further AP2s

cell biology↗